Estimated antiretroviral therapy coverage among people living with HIV in Jamaica
Jamaica: Estimated antiretroviral therapy coverage among people living with HIV was 52.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in Jamaica, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Jamaica recorded 52.0% for estimated antiretroviral therapy coverage among people living with hiv in 2025.
That represents a change of down 3.7% on the previous year and up 48.6% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Jamaica peaked at 54.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Jamaica 122nd out of 143 countries with data for 2025, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in Jamaica, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 1.0% | — |
| 2005 | 5.0% | +400.0% |
| 2006 | 7.0% | +40.0% |
| 2007 | 10.0% | +42.9% |
| 2008 | 13.0% | +30.0% |
| 2009 | 18.0% | +38.5% |
| 2010 | 20.0% | +11.1% |
| 2011 | 23.0% | +15.0% |
| 2012 | 25.0% | +8.7% |
| 2013 | 30.0% | +20.0% |
| 2014 | 32.0% | +6.7% |
| 2015 | 35.0% | +9.4% |
| 2016 | 38.0% | +8.6% |
| 2017 | 41.0% | +7.9% |
| 2018 | 44.0% | +7.3% |
| 2019 | 50.0% | +13.6% |
| 2020 | 46.0% | -8.0% |
| 2021 | 49.0% | +6.5% |
| 2022 | 52.0% | +6.1% |
| 2023 | 52.0% | +0.0% |
| 2024 | 54.0% | +3.8% |
| 2025 | 52.0% | -3.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.4% | 0.0% | 18.0% | 10 |
| 2010s | 33.8% | 20.0% | 50.0% | 10 |
| 2020s | 50.8% | 46.0% | 54.0% | 6 |
Countries ranked near Jamaica
More health data for Jamaica
- Un projection of annual infant deaths, annual growth rate -3.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3325 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,308 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.64 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0278 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.6 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Jamaica?
- Estimated antiretroviral therapy coverage among people living with hiv in Jamaica was 52.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Jamaica?
- The highest recorded value was 54.0% in 2024.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Jamaica?
- The lowest recorded value was 0.0% in 2000.
- How does Jamaica rank for estimated antiretroviral therapy coverage among people living with hiv?
- Jamaica ranks 122nd out of 143 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Jamaica?
- Over the last ten years it is up 48.6%. The long-run trend across the full record is volatile.
- Where does this Jamaica data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).